BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 24280311)

  • 1. Prognostic difference between paroxysmal and non-paroxysmal atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Yashiro B; Minami Y; Terajima Y; Hagiwara N
    J Cardiol; 2014 Jun; 63(6):432-7. PubMed ID: 24280311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertrophic cardiomyopathy in the elderly: significance of atrial fibrillation.
    Doi Y; Kitaoka H
    J Cardiol; 2001; 37 Suppl 1():133-8. PubMed ID: 11433817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragmented QRS predicts heart failure progression in patients with hypertrophic cardiomyopathy.
    Nomura A; Konno T; Fujita T; Tanaka Y; Nagata Y; Tsuda T; Hodatsu A; Sakata K; Nakamura H; Kawashiri MA; Fujino N; Yamagishi M; Hayashi K
    Circ J; 2015; 79(1):136-43. PubMed ID: 25381793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enlarged left atrium and sudden death risk in hypertrophic cardiomyopathy patients with or without atrial fibrillation.
    Minami Y; Haruki S; Yashiro B; Suzuki T; Ashihara K; Hagiwara N
    J Cardiol; 2016 Dec; 68(6):478-484. PubMed ID: 26908359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Kubo T; Baba Y; Ochi Y; Hirota T; Yamasaki N; Kawai K; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
    ESC Heart Fail; 2021 Dec; 8(6):5022-5030. PubMed ID: 34472710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Paroxysmal atrial fibrillation: main cause of syncope in hypertrophic cardiomyopathy].
    Brembilla-Perrot B; Terrier de La Chaise A; Beurrier D
    Arch Mal Coeur Vaiss; 1993 Nov; 86(11):1573-8. PubMed ID: 8010857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical profile and prognostic significance of atrial fibrillation in hypertrophic cardiomyopathy.
    Tian T; Wang Y; Sun K; Wang J; Zou Y; Zhang W; Bao J; Zhu L; Shen H; Hui R; Zhou X; Song L
    Cardiology; 2013; 126(4):258-64. PubMed ID: 24157592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arrhythmia and hypertrophic cardiomyopathy.
    Shakespeare CF; Keeling PJ; Slade AK; McKenna WJ
    Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():31-6. PubMed ID: 1307192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy.
    Sridharan A; Maron MS; Carrick RT; Madias CA; Huang D; Cooper C; Drummond J; Maron BJ; Rowin EJ
    J Cardiovasc Electrophysiol; 2022 Jan; 33(1):20-29. PubMed ID: 34845799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.
    Adabag AS; Casey SA; Kuskowski MA; Zenovich AG; Maron BJ
    J Am Coll Cardiol; 2005 Mar; 45(5):697-704. PubMed ID: 15734613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features and significance of hypertrophic cardiomyopathy with atrial fibrillation].
    Samukawa M; Hasegawa K; Harada Y; Nakao M; Tadaoka S; Yoneda M; Fujiwara T; Nakamura T; Nezuo S; Sawayama T
    J Cardiol; 1987 Sep; 17(3):465-74. PubMed ID: 3453843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
    Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stroke and Embolic Events in Hypertrophic Cardiomyopathy: Risk Stratification in Patients Without Atrial Fibrillation.
    Haruki S; Minami Y; Hagiwara N
    Stroke; 2016 Apr; 47(4):936-42. PubMed ID: 26941260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive risk stratification prevents sudden death due to paroxysmal atrial fibrillation in hypertrophic cardiomyopathy.
    Limongelli G; Elliott PM; Pacileo G; Sarubbi B; Thaman R; Calabrò P; Vergara P; Iacomino M; Russo MG; Calabrò R
    J Cardiovasc Med (Hagerstown); 2006 Sep; 7(9):711-3. PubMed ID: 16932087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.
    Bunch TJ; Munger TM; Friedman PA; Asirvatham SJ; Brady PA; Cha YM; Rea RF; Shen WK; Powell BD; Ommen SR; Monahan KH; Haroldson JM; Packer DL
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1009-14. PubMed ID: 18479329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Rowin EJ; Hausvater A; Link MS; Abt P; Gionfriddo W; Wang W; Rastegar H; Estes NAM; Maron MS; Maron BJ
    Circulation; 2017 Dec; 136(25):2420-2436. PubMed ID: 28916640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased risk of sudden and non-sudden cardiovascular death in patients with atrial fibrillation/flutter following acute myocardial infarction.
    Pedersen OD; Abildstrøm SZ; Ottesen MM; Rask-Madsen C; Bagger H; Køber L; Torp-Pedersen C;
    Eur Heart J; 2006 Feb; 27(3):290-5. PubMed ID: 16267070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation in hypertrophic cardiomyopathy: A turning point towards increased morbidity and mortality.
    Zegkos T; Efthimiadis GK; Parcharidou DG; Gossios TD; Giannakoulas G; Ntelios D; Ziakas A; Paraskevaidis S; Karvounis HI
    Hellenic J Cardiol; 2017; 58(5):331-339. PubMed ID: 28219794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.
    Prinz C; Schwarz M; Ilic I; Laser KT; Lehmann R; Prinz EM; Bitter T; Vogt J; van Buuren F; Bogunovic N; Horstkotte D; Faber L
    Can J Cardiol; 2013 Mar; 29(3):358-63. PubMed ID: 22749647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.